All Q1 FY27 results →
AD

Aster DM Quality Care Ltd

Q1 FY27

Aster DM Quality Care Q1 FY27 earnings call: Revenue & Margins

Q1 FY27 earnings call: what management said on revenue, margins and capex.

Price₹674
Market cap₹58.8K Cr
P/E162.9
Updated16 Oct 2026
Read4 min read

Aster DM Quality Care Ltd Q1 FY27 key numbers

Revenue
Over 2 million patients treated in Q1, up 13% YoY; blended occupancy increased by 510 bps to 64%.

As stated in Aster DM Quality Care Ltd's Q1 FY27 earnings call transcript · published 25 Aug 2026. Reported figures, not investment advice.

The short version

Revenue growth driven by higher patient volumes and increased realizations due to complex case mix. EBITDA margin target of 24%-25% expected within 2-3 years post-merger, with a good exit from FY27 and reaching targets between FY28-FY29.

From Aster DM Quality Care Ltd's Q1 FY27 earnings-call transcript · updated 16 Oct 2026.

Revenue & Sales Performance

Good growth
  • Revenue growth driven by higher patient volumes and increased realizations due to complex case mix.
  • Over 2 million patients treated in Q1, up 13% YoY; blended occupancy increased by 510 bps to 64%.
  • Mature Units (73% revenue) grew 19% YoY; Focus Units (15% revenue) grew 16% YoY; Emerging Units grew 63% YoY.
  • Emerging hospitals like Kasaragod achieved fast ramp-up, reaching EBITDA breakeven in 9 months.
  • Organic growth target: 5%-6% volume growth and 7%-8% ARPP growth.
  • Medical Value Travel (MVT) revenue growing 62% YoY; management aims to grow MVT faster than overall business, targeting mid to double-digit share in revenue.

2 more points from Aster DM Quality Care Ltd's call on revenue

Create a free account to keep reading this call

Profitability & Margins

See what Aster DM Quality Care Ltd said on profitability & margins — free account, 30 seconds.

Capital Expenditure Plans

Capex planned
  • Bhubaneswar project is on the radar for expansion.
  • New cancer center inauguration planned in Raipur by mid-August 2026.
  • Capacity additions planned in 2028 at Kottayam and Nagercoil (bed additions ongoing).
  • Bed additions also happening at Banjara Hills, Nampally, and Shifa by 2028.
  • Greenfield projects include Trivandrum hospital expected operational by H2 FY27 (~January 2027).
  • Hyderabad hospital in interior work phase; planned operationalization by April 2027 (FY28 start).
  • Sarjapur project (~450 beds, two blocks) work already started on Block 1 focused on MEP and interiors.
  • Annual bed capacity increase and expansions, both brownfield and greenfield, are actively being pursued with detailed updates to be shared.

2 more points from Aster DM Quality Care Ltd's call on capex

Create a free account to keep reading this call

Fundraising & Capital Structure

See what Aster DM Quality Care Ltd said on fundraising & capital structure — free account, 30 seconds.

Order Book & Pipeline

See what Aster DM Quality Care Ltd said on order book & pipeline — free account, 30 seconds.

What the Q1 FY27 call signalled

3 of 3 strong

RevenueGood growth
MarginMargins up
CapexCapex planned

Aster DM Quality Care Ltd — Quarterly revenue & net profit

Revenue Net profit
Dec 2024Q3 FY25
Mar 2025Q4 FY25
Jun 2025Q1 FY26
Sep 2025Q2 FY26
Dec 2025Q3 FY26
Mar 2026Q4 FY26

Q1 FY27 figures are not in this chart yet. Latest shown: Mar 2026 (Q4 FY26). The Q1 FY27 numbers from the filing are in the analysis on this page.

Reported quarterly figures (₹ Cr). Latest (Q4 FY26): revenue ₹1.2K Cr, net profit ₹154 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.

Full financials →

Others in Healthcare Services this season

  • Aatmaj Health (Q1 FY27)

    Revenue for Q1 FY 2026-27: ₹8.13 crore . Key investor presentation takeaways from Aatmaj Healthcare Ltd's Q1 FY27 investor presentation — and how it ranks again

  • Asarfi Hospital Ltd (Q1 FY27)

    Q1'FY27 consolidated revenue from operations: ₹47.5 Cr, up 32.8% YoY (vs ₹35.7 Cr in Q1'FY26) . Key investor presentation takeaways from Asarfi Hospital Ltd's Q

  • KMC Speciality (Q1 FY27)

    Q1 FY'27 Revenue from operations: INR 91.8 Cr, up 38% YoY from INR 66.6 Cr in Q1 FY'26. Key concall takeaways from KMC Speciality Hospitals (India) Ltd's Q1…

  • 3B Blackbio (Q1 FY27)

    Q1 2026-27 revenue from operations: ₹3,205.73 Lakh (including Coris sales of ₹862.83 Lakh) vs ₹1,996.06 Lakh in Q1 2025-26 — YoY growth approx. Key concall…

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →

Arthneeti Pro · Annual

Aster DM Quality Care Ltd and 15K+ more earnings calls,
for less than your morning chai

a day

Every earnings call, ranking and concall Q&A across all four results seasons.

Secure Razorpay payment · instant access

Frequently Asked Questions

What were Aster DM Quality Care Ltd Q1 FY27 results?

Revenue growth driven by higher patient volumes and increased realizations due to complex case mix. EBITDA margin target of 24%-25% expected within 2-3 years post-merger, with a good exit from FY27 and reaching targets between FY28-FY29.

What is Aster DM Quality Care Ltd share price analysis?

Aster DM Quality Care Ltd currently shows a moderate growth signal based on ranking data. The stock trades at a P/E of 162.9 with a market cap of ₹58,781 Cr. Investors should review the full earnings analysis for detailed insights.

Is Aster DM Quality Care Ltd planning capital expenditure?

Bhubaneswar project is on the radar for expansion. - New cancer center inauguration planned in Raipur by mid-August 2026. - Capacity additions planned in 2028 at Kottayam and Nagercoil (bed additions ongoing). - Bed additions also happening at Banjara Hills, Nampally, and Shifa by 2028. - Greenfield projects include Trivandrum hospital expected operational by H2 FY27 (~January 2027). - Hyderabad hospital in interior work phase; planned operationalization by April 2027 (FY28 start). - Sarjapur project (~450 beds, two blocks) work already started on Block 1 focused on MEP and interiors.

Keep Aster DM Quality Care Ltd on your radar — track it to get its next earnings analysis in your feed.

This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.